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Hindsight, Insight, Foresight 
Ames Research Center 
Ames Research Center 
Prevent Death"
Ames Research Center All Intensive Care Wards Worldwide are based on Apollo Medical Telemetry 
Ames Research Center 
Enable Life"
Ames Research Center 
Collaborative 
development efforts 
with UCSF Fetal 
Treatment Center 
Spinoff:  Fetal Biotelemetry System"
• Fetal Health Status Monitor  
• pH/temp/HR Fetal Biotelemetry System 
• pH/temp/ECG/pressure Fetal Biotelemetry System 
NASA Ames Exploration Probes and Small Satellites Group 
Ames Research Center 
Generate Wealth"
Ames Research Center 
pump 
Fluid  
path 
reactor 
mixer motor 
Biotech-Infotech-Superminiaturization revolutions amplify the value of a 
payload pound to space a million times or more over what was possible 5 
years ago.  Space Bio MEMS advances generate $2B+ annually 
NASA Ames Exploration Probes and Small Satellites Group 
Ames Research Center 
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What’s New Since 
the Last Time We 
Went to the Moon?"
Ames Research Center 
PARADIGM !
BUSTERS!"
"
Biotech revolution"
"
Infotech revolution"
"
MEMS /nanotechnology"
Opens previously 
inaccessible biological 
regions"
"
Amplifies the value of a 
biosciences payload 
pound by orders of 
magnitude"
"
Reveals features of 
terrestrial life that cannot 
be seen on Earth"
Technology Revolutions"
Ames Research Center 
Astronomy biology parallels"
The biotech revolution provided the 
equivalent of a Hubble Space 
Telescope for Space Biosciences"
"
"
"
"
Ames Research Center 
Mouse Retina	 The Glowing Eye of NGC 6751	
Ames Research Center 
Mouse Retina	 The Glowing Eye of NGC 6751	
Retina of a Mouse’s Eye 
Star Exploding 
Ames Research Center 
Ames Research Center 
Molecular Cloud in Space 
Light years distant, light years in size 
Cytoskeleton of a Cell 
Less than 100 microns 
Ames Research Center 
Ames Research Center 
Nucleus, mitochondria, cytoskeleton 
Of a cell less than 100 microns  
Birthplace of more than 700 stars 
Light years from Earth 
Light years in size  
Ames Research Center 
Ames Research Center 
A drop of seawater 
With only the DNA illuminated 
Small “stars” are viruses 
Medium “stars” are bacteria 
Galactic looking object is a diatom 
Hubble Space 
Telescope 
Deepfield Study 
12 billion light years 
Ames Research Center 
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Investigations"
■  Emerging Space Office (ESO) Commercial Microgravity Case Studies 2012-present"
◆  Identify high value areas where gravity is limiting American industry and determine whether and 
how the ISS or other U.S. commercial LEO platforms can enable necessary breakthroughs."
◆  Identify where gravity is hindering medical research and applications and determine whether 
and how the ISS or other U.S. commercial LEO platform can contribute to important advances."
■  Space Commercial Laboratory Applications Working Group 2010-2011"
■  ISS National Laboratory Workshop chaired by Nobel Laureate Blumberg October 2007 
with keynote address by Dr. J. Craig Venter identified strategies for implementing the 
ISS as first National Lab beyond Earth that lay the content for the Oct workshop."
■  Commercial Space Forum (May 2006) identified specific development projects and 
teams. "
! ! !!
Ames Research Center 
Background"
■  Emerging Space Office (ESO), reporting to the NASA HQ Chief Technologist, was established in 
2012 to provide economic intelligence on the rapidly developing space ecosystem."
■  One of the first studies was to examine the potential of microgravity to affect the nation’s economy 
and general welfare."
•  Focus was on terrestrial markets rather than NASA applications, applied rather than basic 
research, and commercial rather than academic investigators.  "
•  The ISS was the centerpiece of these studies, but commercial microgravity also affects emerging 
commercial laboratories such as SpaceX DragonLab, Bigelow Aerospace expandable modules, 
and suborbital spacecraft and third tier suppliers like CASIS, Nanoracks, Bioserve, TechShot, etc."
22 
Ames Research Center 
23 
“Extraordinary claims require extraordinary evidence.”	
– Carl Sagan 
Note: The candidate technologies contained in this document do not yet have sufficient 
evidence to confirm their value as marketable products from microgravity manufacturing. 
That is, in fact, the point of the proposed flight activities.  In all cases, we have obtained, 
or are in the process of obtaining independent validation of pre-ISS flight claims and also 
recommend independent validation of ISS flight results. 
Ames Research Center 
Findings"
Many of the problems that hindered space research and space commercial 
development either have been solved or are close to being solved:"
"
■  Technology is ready and often on the shelf to enable discovery and development in space."
■  Wealthy individuals self-financing their own rockets and space stations."
"
■  Flight frequency has increased because of commercial providers"
■  Diverse customer base that wants to fly."
■  Private capital looking towards space for investment opportunities."
■  New customers close or at the point of closing the business case for space products."
■  New space markets identified."
■  Humanitarian space projects identified."
Ames Research Center 
Low-Hanging Fruit"
■  Three case studies for commercial development from microgravity are presented as examples for 
understanding different features of commercial needs/opportunities in the near future.  (There are 
10+ additional areas under investigation.)"
◆  Silicon Carbide Wafers"
◆  Exotic Glasses and Fibers"
◆  3-D Tissue Engineering"
"
■  Case Studies:"
◆  Meet the criteria of a general-purpose technology as defined by NRC"
◆  Offer high probability of significant potential impact of the product on the nation (multiple billions of dollars or 
health benefits affecting millions of people)"
◆  Product clearly requires microgravity for development or improvement"
◆  Companies are actively seeking solutions in microgravity because of 1-g limitations"
◆  Prior microgravity research strongly indicates that the desired product outcome could be achieved in space"
◆  Flight hardware exists now or can be easily modified to enable on-orbit investigations/manufacturing"
"
" 25 
Goals"
■  Reveal the biological 
story of the only life that 
we know during its first 
generations beyond the 
planet of origin."
■  Use the results to enable 
better futures for 
humanity."
■  Generate wealth and 
promote the new space 
economy."
Opportunities: Doing 
Good While Doing Well"
Astronaut Don Pettit 
Space Station Expedition Six 
Speaking at the ISS National Lab Workshop 
“this is why we go to a frontier … to go  
where our intuition no longer applies.” 
Ames Research Center 
Silicon Carbide (SiC) Wafers Summary"
Value of Microgravity Manufactured Product: 
Very High"
■  SiC operates at 1000°C versus 300°C for silicon based 
devices, withstands 10X electric fields over silicon,  
offers high radiation resistance, high thermal 
conductivity, high maximum current density and more"
■  Immediate market.  SiC could replace silicon in hybrid 
and electric cars, enable much faster and much more 
energy efficient computers, provide new sensors for 
extreme environments, and other unique applications"
■  Opens new classes of products and microgravity 
research (e.g. GaN semiconductors)"
■  Component sales estimated well in excess of $10B/
year and growing"
■  Multiple consumer military, energy, NASA applications 
with values many times greater than the wafer sales."
Gravity causes high defects in silicon carbide 
crystal growth on Earth limiting size of 
wafers, increasing manufacturing cost, and 
restricting applications."
28 
See:  http://spectrum.ieee.org/semiconductors/materials/silicon-carbide-smaller-faster-tougher/0 
Devices built atop defects in SiC wafers 
don’t perform as designed.   
 
Even a few defects per square cm erode 
device yield, drive up costs, and hamper 
manufacturing of 6”+ wafers. 
 
 
These defects appear to be significantly reduced 
or absent in µg. 
Ames Research Center 
Silicon Carbide (SiC) Wafers Summary"
■  Readiness:  Manufacturing already proved in space (TRL 7)"
◆  ACME Advanced Materials Inc has flown 100 “junk” 4 inch SiC wafers (sold at $250/wafer), “healed” them in 
space with reported 99% success, which resulted in wafers better the best manufactured on Earth (sold at 
$1500/wafer and shown as the black line in the graph below).  "
◆  100+ wafers can be processed in minutes in space."
◆  Microgravity significantly improves crystal lattice structure resulting in much lower defects"
◆  ACME claims 82% gross margin"
29 
•  ISS could enable expansion into as 
yet unsuccessful production of high 
quality wafers of 6” or more which 
opens even larger markets. 
•  Status:  Independent validation of 
ACME claims by Stanford University 
and Glenn Research Center in 
progress.  ACME has next 
manufacturing flight in January 2015. 
No path to ISS yet. 
 
Source ACME 
Red = after flight processing.  Blue = before flight processing.  Black = Top grade 1-g 
This graph shows the IV response for 100 development grade 4” SiC wafers (II-VI, 
Corning, and C grade Chinese).  Current through the wafer – not lateral.  Note t e wid  
variation in response of the unprocessed wafers versus the processed wafers.   
TOP GRADE 
1-G WAFERS 
Ames Research Center 
“sermo minor, operor 
magis” 
Processing Overview 
This graph shows the power dissipation (through the wafer) for the same 100 
development grade 4” SiC wafers.  Note how much less power is dissipated 
in the processed wafers when compared to the unprocessed wafers. 
Processed Wafers 
Baseline Developmental Wafers 
Baseline A  
Grade Wafers 
30 
Ames Research Center 
“sermo minor, operor 
magis” 
SiC Before and After 
µg Processing  
"
µg > 400 secs 
31 
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Exotic Glasses and Optical Fibers Summary"
■  Value of Microgravity Manufactured Product: Potentially Very High"
◆  Enables unique growing medical, military, sensor, consumer, and communications products estimated > $10B/yr"
◆  Immediate market for some applications, other markets depend on availability of higher quality products.  "
◆  Exotic fibers, e.g. ZBLAN, could replace silicon fiber optics as the backbone of the global communications market"
◆  Even with reasonable launch costs, business cases could close"
◆  Multiple consumer military, energy, NASA applications with values many times greater than the glass or fiber 
sales."
■  Exotic glasses are made by melting together dissimilar and often immiscible materials  Gravity causes 
high defects because of density differences and convection, which constrains length of fibers that can 
be produced."
"
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ZBLAN Component Density Formula 
Lanthanum Fluoride 5.94 g/cm3 LaF3 
Barium Fluoride 4.89 g/cm3 BaF2 
Zirconium Fluoride 4.43 g/cm3 ZrF4 
Aluminum Fluoride 2.88 g/cm3 AlF3 
Sodium Fluoride 2.56 g/cm3 NaF !
Ames Research Center 
Exotic Glasses and Optical Fibers"
33 
Ames Research Center 
Exotic Glasses and Optical Fibers"
■  Readiness:  Parabolic flights showed significant 
improvement in producing ZBLAN preforms and fibers 
(TRL 5) but needs kilometer lengths of superior quality 
fibers to open new markets"
◆  Flight hardware proven on parabolic flights would have to 
be modified for ISS"
◆  Iteration needed before practical manufacturability 
achieved.  In theory, in a ~50kg flight manufacturing unit, 1 
kg of exotic glass preform can produce 3-7 kg of fiber in 
under 30 minutes.  Potential sales value ranges from 
$450K/kg-preform to $21,000K/kg-preform depending on 
composition and quality."
■  ISS could enable demonstrations of the value of 
microgravity for a wide range of exotic glasses and 
fibers, provide R&D environment to perfect µ-g 
manufacturing, and open new market opportunities."
"
34 See:  https://dl.dropboxusercontent.com/u/51989053/%2AZBLAN%20Final%20Report/DRAFT%2010012014%20Exotic%20Fibers%20Case%20Study%20Report.pdf 
Top left:   ZBLAN preform made in 1-g  
Top right: ZBLAN preform made in µg 
 
Bottom left:   ZBLAN fiber made in 1-g 
Bottom right: ZBLAN fiber made in µg 
Status:  Independent validation completed 
of Starodubov claims by MSFC, ThorLabs.  
No path to flight at present but discussions 
in progress with CASIS and Nanoracks. 
Ames Research Center 
3-D Engineered Tissues Summary"
■  Value of Microgravity Manufactured Product: Potentially Very High"
◆  Potentially enables cancer diagnoses and treatments (Vivo Biosciences Case Study), also development of a 
wide range of new medical treatments"
◆  Immediate market for some applications, other markets depend on availability of higher quality products.  "
◆  Meeting significant need for higher quality tissue cultures is hampered by gravity"
"
■  Space Shuttle and ISS showed improvements in size and quality of 3-D Tissues in space however 
this high value area still needs considerable investment and development (TRL 3)"
◆  Managing 3-D tissues in microgravity must be developed such that the tissues exhibit little or no variability 
from spaceflight"
◆  Flight hardware is available and some on ISS to make progress"
■  ISS could enable development of this medically important field, but it will take funding and likely 
consortia conducting iterative research in space."
■  Status:  Independent validation completed of Vivo Biosciences study by Nobel Laureate Baruch 
Blumberg, Dr. Todd Meyyerose/Whitehead Institute.  No path to flight yet."
" 35 
See:  https://dl.dropboxusercontent.com/u/51989053/%2AVivo%20Biosciences%20Final%20Report/09242013Vivo%20Biosciences%20Final%20Report.pdf 
1982 – 2000 



Space Biosciences  
Before 1998 
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Why Space for Biotech?"
■  Good cell/tissue cultures reduce the time to the discovery of the cause of a 
disease and evaluation of potential cures by years to decades saving millions to 
billions of dollars and lives."
■  The value of a cell/tissue culture depends entirely on how well the culture 
mimics what happens in the body."
■  The cells are not smart but they are adaptable.  Give them the wrong 
environmental information and they will respond biologically in medically 
misleading ways. "
■  The size and complexity of a tissue culture is limited on Earth by gravity."
■  Similarly high quality protein crystals accelerate drug discovery.  The size and 
quality of some of the world’s most medically important proteins is limited by 
gravitationally driven convection forces."
Cartilage - relevance: 
Osteoporosis 
Colon Cancer - 
Superior assembly 
Beginning of  
differentiation  
Protein Crystallization"
Why grow crystals in space? 
 
The limiting step in solving complex three-dimensional protein structures needed for drug 
discovery is often the ability to crystallize specific proteins with sufficient size and crystalline 
quality to obtain the high resolution X-ray diffraction patterns needed to solve their 
structure.  
 
Crystals often will grow larger and with much better internal order, 
if made in microgravity. 
 
X-ray diffraction data from more than 33 space-grown crystals revealed structures in much 
more detail than ever before, and allowed the structure of some proteins to be determined 
for the first time. 
 
Space grown proteins ranging from insulin to HIV reverse transcriptase, demonstrated that 
the microgravity environment improved crystal growth over the best-case Earth-grown 
crystals in the following ways: 
 
•  Larger Crystals in 45.4% of the cases 
•  New Crystal Structures in 18% of the cases 
•  10+% increase in the X-Ray Crystallography Brightness in 58% of the cases 
•  Less thermal motion in 27.2% of the cases 
•  X-Ray Crystallography resolution improved ~0.3 Angstroms in 42.4% of the cases 
•  X-Ray Crystallography resolution improved 0.3 to 0.5 Angstroms in 9.9% of the cases 
•  X-Ray Crystallography resolution improved 0.5 to 1.0 Angstroms in 9.9% of the cases 
 
In the improvement of resolution, a 1 Angstrom improvement can mean the three-dimensional 
structure can be determined and atomic positions in the macromolecule can be resolved. 
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A New Entrepreneurial Paradigm For The International Space Station 
Santa Clara, CA  •  June 21-22, 2005 
The Space Biotech Case 
Space Biotech offers the potential of  life saving advances addressing the world’s top medical 
issues with $100B+ per year total available market potential. 
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A New Entrepreneurial Paradigm For The International Space Station 
Santa Clara, CA  •  June 21-22, 2005 
■  Past successes are significant and the future potential much greater.  Over the past 
30 years, space biosciences research has delivered life-saving and life-enhancing products that today 
yield more than $2B a year in product revenue (conservative estimate). Because of the biotech 
revolution, the promise for future dividends from space biotech research is even greater. The 
worldwide market for just 3 high potential areas -- infectivity, 3-D cell/tissue cultures, and plant 
products -- is more than $100B per year."
The Space Biotech Case 
Space Biotech offers the potential of  life saving advances addressing the world’s top medical 
issues with $100B+ per year total available market potential. 
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A New Entrepreneurial Paradigm For The International Space Station 
Santa Clara, CA  •  June 21-22, 2005 
■  Past successes are significant and the future potential much greater.  Over the past 30 years, space 
biosciences research has delivered life-saving and life-enhancing products that today yield more than $2B a year in 
product revenue (conservative estimate) (ref1). Because of the biotech revolution, the promise for future dividends 
from space biotech research is even greater. The worldwide market for just 3 high potential areas -- infectivity, 3-D cell/
tissue cultures, and plant products -- is more than $100B per year (ref.2) ."
■  Knowledge, not in-space manufacturing, is the important ROI in early ISS 
research. Once the knowledge of what factors governed gene expression and biochemical 
interaction is revealed in space, the results can be replicated and fine-tuned on the ground leading to 
new pharmaceutical products."
The Space Biotech Case 
Space Biotech offers the potential of  life saving advances addressing the world’s top medical 
issues with $100B+ per year total available market potential. 
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A New Entrepreneurial Paradigm For The International Space Station 
Santa Clara, CA  •  June 21-22, 2005 
■  Past successes are significant and the future potential much greater.  Over the past 30 years, space 
biosciences research has delivered life-saving and life-enhancing products that today yield more than $2B a year in 
product revenue (conservative estimate) (ref1). Because of the biotech revolution, the promise for future dividends 
from space biotech research is even greater. The worldwide market for just 3 high potential areas -- infectivity, 3-D cell/
tissue cultures, and plant products -- is more than $100B per year (ref.2) ."
■  Knowledge, not in-space manufacturing, is the important ROI in early ISS research. Once the knowledge 
of what factors governed gene expression and biochemical interaction is revealed in space, the results can be 
replicated and fine-tuned on the ground leading to new pharmaceutical products."
■  Microgravity causes different physical features of the growth environment to 
become dominant, eliciting valuable biological responses, and opportunities for 
unique manipulations of the environment.  These features can be important for 3 
dimensional cell and tissue culture and protein crystallization, relevant to cancer research, 
infectious disease research, development of organ bandages, and aging research. "
The Space Biotech Case 
Space Biotech offers the potential of  life saving advances addressing the world’s top medical 
issues with $100B+ per year total available market potential. 
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A New Entrepreneurial Paradigm For The International Space Station 
Santa Clara, CA  •  June 21-22, 2005 
■  Past successes are significant and the future potential much greater.  Over the past 30 years, space 
biosciences research has delivered life-saving and life-enhancing products that today yield more than $2B a year in 
product revenue (conservative estimate) (ref1). Because of the biotech revolution, the promise for future dividends 
from space biotech research is even greater. The worldwide market for just 3 high potential areas -- infectivity, 3-D cell/
tissue cultures, and plant products -- is more than $100B per year (ref.2) ."
■  Knowledge, not in-space manufacturing, is the important ROI in early ISS research. Once the knowledge 
of what factors governed gene expression and biochemical interaction is revealed in space, the results can be 
replicated and fine-tuned on the ground leading to new pharmaceutical products."
■  Microgravity causes different physical features of the growth environment to become dominant, 
eliciting valuable biological responses.  These features can be important for 3 dimensional cell and tissue culture 
and protein crystallization, relevant to cancer research, infectious disease research, development of organ bandages, 
and aging research. "
■  Rapid turnaround and high throughput are required.  Space investigations must meet 
current biotech throughput standards.  Nominally this means launches of live specimens and research 
equipment at least monthly; experiments iterated within weeks; and 2-3 kilograms of samples 
returned to Earth approximately monthly."
The Space Biotech Case 
Space Biotech offers the potential of  life saving advances addressing the world’s top medical 
issues with $100B+ per year total available market potential. 
2000-Present 
Ames Research Center 
■  Is it worth it? "
◆  Large market size"
◆  Reasonable R&D investment"
◆  Large projected profit"
■  Is it real?"
◆  Proven science"
◆  Manufacturable product"
◆  Low government uncertainty"
■  Can we win? Is product specific"
◆  Best management team"
◆  High competitive entry barriers"
"
Venture Capitalists  
Recommended Focus Areas for Space Biotech"
Ames Research Center 
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■  Is it worth it? YES"
◆  Large market size? YES"
◆  Reasonable R&D investment"
◆  Large projected profit? YES"
■  Is it real?"
◆  Proven science"
◆  Manufacturable product? YES"
◆  Low government uncertainty"
■  Can we win? Is product specific"
◆  Best management team?"
◆  High competitive entry barriers?"
"
Venture Capitalists  
Recommended Focus Areas for Space Biotech"
Not Enough Yet 
No 
Close, needs more 
Ames Research Center 
Primarily Government"
Some Private Investors"
3-D"
Tissues"
ZBLAN"
TRL 1"
Basic 
principles 
observed 
TRL 2"
Technology 
application 
formulated 
TRL 3"
Laboratory 
Proof of 
Concept 
TRL 4"
Component/ 
breadboard 
tested in lab 
TRL 6"
System 
prototype"
Demo in 
relevant 
environment  
TRL 5"
Component/ 
breadboard 
validated in 
relevant 
environment  
TRL 7"
System 
prototype"
Demo in 
operational 
environment  
TRL 8"
Actual system 
completed 
and qualified 
by demo 
TRL 9"
Actual system 
proven 
through 
successful 
real world 
applications 
ESO Microgravity Case Studies"
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Carbide"
Wafers"
Primarily Government"
"
Internal IRAD"
Angel Investors"
Philanthropists"
Primarily Private Investors"
Some Govt Support/Subsidies"
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2011 
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Approach"
■  Conduct research to demonstrate the value proposition to 
commercial biotech. (What needs to be demonstrated – 
Question for this group)"
■  Demonstrate that the logistics train works and delivers samples 
of sufficient quality to warrant the cost frequently enough to 
enable iteration and rapid learning."
■  The payload costs must be reasonable."
■  Message to NASA - Commercial biotech companies are not 
going to pay for suppliers to demonstrate the value proposition 
to them … or … that the logistics chain works."
■  NASA/government will need to prime the pump."
2016 
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Summary"
■  By removing gravity, growing 3-D cell and tissue cultures in space has the 
potential to yield much higher larger and much higher quality cultures than can 
currently be achieved on Earth for certain cultures.  This was most recently 
demonstrated by Dr. Cheryl Nickerson et al for salmonella infectivity and human 
lung tissue (2010)."
■  Tissue cultures already grown in space show important properties and some 
superior features to terrestrial cultures even on the first investigations, but no 
one has put together a concerted effort to standardize and optimize tissue 
cultures in space."
■  The kind of iteration needed for space laboratory sciences, including optimizing 
space-grown tissue cultures for medical research, is only now becoming 
possible because of entrepreneurial space companies and ISS."
■  The next step might be to identify cell and tissue culture targets of 
interest, establish performance criteria, and fly them as soon as feasible in 
existing systems to analyze where improvements need to be made."
Nobel Laureate Baruch S. Blumberg and Human Genome 
Project Pioneer J. Craig Venter 
speaking at the ISS National Laboratory Workshop 
“The ISS has many aspects of a field station in addition to its role as a laboratory.   
 
It is in a remote location – in fact very remote.” 
	
"
“But, the opportunities for new observations compensate for the difficulties.” 
Nobel Laureate Baruch Blumberg 
ISS National Laboratory Workshop 
Baruch Blumberg’s Last Words"
“The project should focus at 
each of its phases on 
achieving the goal,  
 
but also on expecting the 
unexpected and  
 
assigning resources to 
pursue unexpected findings 
to new scientific, applied, 
and commercial outcomes.” 
 
Heraclitus (c.535 BC - 475 BC): "If you do not expect the unexpected, 
you will not find it; for it is hard to be sought out, and difficult".  
Baruch Blumberg’s Last Words"
"Inexperience of the volunteers proved to be advantageous in that it shielded data collection 
against preconceived biases. The professionals often had narrow views on what they were looking 
for during the dig, while the volunteers were more open to finding a variety of things” 
 (Barreto, Fastovsky, and Sheehan (2003) 
Citizen Science can be an 
important feature of the 
project.   
 
This can generate new ideas 
as there are many more 
participants,  
 
and amateurs often see 
things professionals do not.  
This is the biological story of the only life in the Universe that 
we know in our first generations beyond the planet of origin. 
 
Space is evolutionarily novel with 5+ orders of magnitude 
changes in one of the fundamental organizing forces of nature: 
gravity. 
 
Very different futures are available to a species that can thrive 
beyond their planet of origin, versus those whose destinies are 
constrained to a single world. 

